Cao Sean Wuxiong exercised Options for 339,372 NovaBridge Biosciences shares across two transactions on 2026-09-03. The transactions leave the chief Business development officer with 374,445 shares, while his derivative-securities holding stood at 135,960, giving investors an updated view of his reported ownership.

Key Highlights

  • The transactions were recorded on 3 September 2026 under SEC transaction code M.
  • The exercises involved 147,553 derivative securities at $0 per share.
  • Cao Sean Wuxiong held 135,960 derivative securities after the transactions.

NovaBridge Biosciences (NASDAQ: NBP) officer Cao Sean Wuxiong exercised options for 339,372 shares across two transactions. The chief business development officer held 374,445 shares after the transactions.

Option Exercise Covers 147,553 Derivative Securities

The transactions also involved 147,553 derivative securities. Those securities were exercised at $0 per share. The activity was recorded on 3 September 2026. Cao Sean Wuxiong held 135,960 derivative securities following the transactions.